M. Watanabe et al., [H-3] CLOPROPYLMETHYL)-4-(2-(4-FLUOROPHENYL)-2-OXOETHYL) PIPERIDINE HBR (DUP 734) - A SELECTIVE LIGAND FOR SIGMA-RECEPTORS IN MOUSE-BRAIN IN-VIVO, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1541-1548
clopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP
734) is a novel sigma receptor ligand which exhibits promise in precl
inical animal models as an antipsychotic agent without motor side effe
cts. In vitro and in vivo receptor binding profiles of DuP 734 in mous
e brain using [H-3]DuP 734 and [H-3]N-allylnormetazocine ((+)-SKF 10,0
47) were studied. The pharmacology and stereospecificity of [H-3]DuP 7
34-labeled sites in mouse brain, both in vitro and in vivo, was consis
tent with sigma receptor pharmacology. Specific in vivo binding of [H-
3]DuP 734 in brain peaked 1 hr after i.v. injection and this level of
binding was maintained up to 4 hr. On the other hand, plasma concentra
tion of [H-3]DuP 734 decreased rapidly within 20 min after injection,
indicating different pharmacokinetics between brain and plasma levels.
Nonspecific binding, defined using 1 mg/kg (2.66 mumol/kg) of haloper
idol, was approximately 30% of total binding 1 hr after injection of r
adiotracer. Administration of DuP 734 potently antagonized the binding
of [H-3]DuP 734 and [H-3](+)-SKF 10,047 to brain sigma receptors in v
ivo with ID50 values of 0.02 and 0.07 mg/kg (0.07 and 0.25 mumol/kg),
respectively. However, (+)-SKF 10,047, which posses a high affinity (I
C50 = 22.5 nM) for [H-3]DuP 734 binding in vitro, failed to displace [
'H]DuP 734 binding in vivo. Thus in vitro receptor binding data may no
t predict in vivo receptor occupancy. Overall, the data suggest [H-3]
DuP 734 is a good ligand for in vivo imaging of sigma receptors.